Immunosis

Melbourne, Australia Founded: 2015 • Age: 11 yrs
Developer of a diagnostic platform for diagnosing patients with immune dysfunctions
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Immunosis

Immunosis is a company based in Melbourne (Australia) founded in 2015. Immunosis offers products and services including Prim-Dx. Immunosis operates in a competitive market with competitors including Everlywell, Viome, Color, Strand Life Sciences and Invitae, among others.

  • Headquarter Melbourne, Australia
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Immunosis Pty Ltd
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Immunosis

Immunosis offers a comprehensive portfolio of products and services, including Prim-Dx.

Product name locked
Category locked
Primary

Diagnostic test for primary immune deficiency using blood analysis.

Funding Insights of Immunosis

Premium access

Detailed funding history for Immunosis

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Immunosis

Investments
Premium access

Investment portfolio details for Immunosis

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Immunosis

Premium access

Detailed financials for Immunosis

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Immunosis Comparisons

Immunosis Primary company
Description
Developer of a diagnostic platform for diagnosing patients w...
Location
Melbourne, Australia
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Immunosis

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Immunosis

Immunosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Viome, Color, Strand Life Sciences and Invitae, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
At-home health tests for biomarkers, nutrition, and hormone analysis.
Locked Locked Locked
Machine learning-based bioinformatics solutions for health insights are provided.
Locked Locked Locked
Cancer care is delivered through a virtual clinic by Color.
Locked Locked Locked
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Locked Locked Locked
Home-based genetic tests for detecting diseases are provided to individuals.
Locked Locked Locked
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
Premium access

Detailed competitors of Immunosis

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Immunosis

Premium access

Complete news archive for Immunosis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Immunosis

Immunosis was founded in 2015.

Immunosis is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.

Simon Green is the current CEO of Immunosis.

Immunosis was founded in 2015 in Melbourne, Australia, within the healthcare diagnostics sector. A technology platform named Prim-Dx is being developed to identify Primary Immune Deficiency (PID) and Secondary Immune Deficiency (SID). Proprietary software algorithms are utilized to analyze patient data for accurate diagnosis. Operations are centered on advancing immune dysfunction detection tools, with a focus on clinical applications in immunology.

Immunosis's top competitors include Strand Life Sciences, Viome and Variant Bio.

Immunosis offers Prim-Dx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available